Federal Register / Vol. 60, No. 52 / Friday, March 17, 1995 / Notices 14439

beginning approximately 90 days after

the meeting.

This notice is issued under section

10(a)(1) and (2) of the Federal Advisory

Committee Act (5 U.S.C. app. 2), and

FDA’s regulations (21 CFR part 14) on

advisory committees.

Dated: March 13, 1995.

Lireka P. Joseph,

Acting Deputy Commissioner for Operations.

[FR Doc. 95–6692 Filed 3–16–95; 8:45 am]

BILLING CODE 4160–01–F

National Institutes of Health

National Cancer Institute; Notice of

Meetings

Pursuant to Pub. L. 92–463, notice is

hereby given of the meetings of the

National Cancer Institute for April and

May 1995.

These meetings will be open to the

public to discuss administrative details

or other issues relating to committee

activities as indicated in the notice and

for the review of concepts being

considered for funding. Attendance by

the public will be limited to space

available.

These meetings will be closed to the

public as indicated below in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications and

contract proposals. These applications

and proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the applications and proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

Ms. Carole Frank, the Committee

Management Officer, National Cancer

Institute, Executive Plaza North, Room

630E, 6130 Executive Blvd MSC 7405,

Bethesda, Maryland 20892–7405, (301–

496–5708) will provide a summary of

the meetings and the roster of

committee members, upon request.

Other information pertaining to the

meetings may be obtained from the

contact person indicated below.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodation, should

contact the Executive Secretary/

Scientific Review Administrator listed

for that particular meeting.

Committee name: Cancer Centers and

Research Programs Review Committee—

Subcommittee D.

Contact person: Dr. John W. Abrell,

Scientific Review Administrator, National

Cancer Institute, Bldg. EPN, Room 635B,

6130 Executive Blvd MSC 7405, Bethesda,

MD 20892–7405, Telephone: (301) 496–9767.

Date of meeting: April 11–12, 1995.

Place of meeting: The Holiday Inn Crowne

Plaza, 1750 Rockville Pike, Rockville, MD

20852.

Closed: 8 am to adjournment.

Agenda: Review, discussion and

evaluation of individual grant applications.

Committee name: Biometry and

Epidemiology Contract Review Committee.

Contact person: Dr. Harvey P. Stein,

Scientific Review Administrator, National

Cancer Institute, Bldg. EPN, Room 601C,

6130 Executive Blvd MSC 7405, Bethesda,

MD 20892–7405, Telephone: (301) 496–7030.

Date of meeting: April 12–13, 1995.

Place of meeting: Conference Room G, 6130

Executive Blvd., Rockville, MD 20852.

Closed: 9 am to adjournment.

Agenda: Review, discussion and

evaluation of individual contract proposals.

Committee name: Acrylonitrile Study

Advisory Panel.

Contact person: Dr. Aaron Blair, Executive

Secretary, National Cancer Institute, 6130

Executive Blvd., Room 418, Rockville, MD

20852, Telephone: (301) 496–9093.

Date of meeting: May 3, 1995.

Place of meeting: Conference Rooms 1 & 2,

6100 Executive Blvd., Rockville, MD 20852.

Open: 10 am to adjournment.

Agenda: Review and discussion of study

progress.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control.)

Dated: March 13, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6570 Filed 3–16–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Deafness and

Other Communication Disorders;

Notice of Meeting of the Ad Hoc

Hearing and Hearing Impairment

Subcommittee of the National

Deafness and Other Communication

Disorders Advisory Council

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the Ad

Hoc Hearing and Hearing Impairment

Subcommittee of the National Deafness

and Other Communication Disorders

Advisory Council on April 6, 1995. The

meeting will take place from 1 p.m. to

4 p.m. in Conference Room 9, Building

31C, National Institutes of Health, 9000

Rockville Pike, Bethesda, Maryland

20892, and will be conducted as a

telephone conference with the use of a

speaker phone.

The meeting, which is open to the

public, will be held to discuss changes

in the scientific field of hearing and

hearing impairment since the Research

Plan was written, compare the research

portfolio of the Institute with the

priorities in the Research Plan to

determine areas of emphasis and levels

of activity, and to identify gaps and to

suggest new initiatives in preparation

for the updating of the hearing and

hearing impairment section of the

Research Plan. Attendance by the public

will be limited to the space available.

Summaries of the Subcommittee’s

meeting and a roster of members may be

obtained from Mr. Baldwin Wong,

Program Analyst, National Institute on

Deafness and Other Communication

Disorders, Building 31, Room 3C08,

National Institutes of Health, Bethesda,

Maryland 20892, (301) 402–1129, upon

request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Mr. Wong in advance of the

meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.173, Biological Research

Related to Deafness and Communication

Disorders)

Dated: March 13, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6569 Filed 3–16–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Dental Research;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Dental Research

Special Emphasis Panel (SEP) meetings.

Name of SEP: National Institute of Dental

Research Special Emphasis Panel-Perio.

Complications of Diabetes.

Dates: April 13, 1995.

Time: 9:00 a.m.

Place: Natcher Building, NIH, Conf. Center

A.

Contact Person: Dr. Yong Shin, Scientist

Review Administrator, 4500 Center Drive,

Natcher Building, Room 4AN–38J, Bethesda,

MD 20892, (301) 594–2372.

Purpose/Agenda: To evaluate and review

grant applications and/or contract proposals.

Name of SEP: National Institute of Dental

Research Special Emphasis Panel-Sensor for

High Resolution (Teleconference).

Dates: April 17, 1995.
14440 Federal Register / Vol. 60, No. 52 / Friday, March 17, 1995 / Notices

Time: 11:00 a.m..

Place: Natcher Building, NIH, Conf. Rm.

4AS–10.

Contact Person: Dr. H. George Hausch,

Chief, Review Section, 4500 Center Drive,

Natcher Building, Room 4AN–38J, Bethesda,

MD 20892, (301) 594–2372.

Purpose/Agenda: To evaluate and review

grant applications and/or contract proposals.

Name of SEP: National Institute of Dental

Research Special Emphasis Panel–R03,

Special Small Grants.

Dates: April 18, 1995.

Time: 11:00 a.m.

Place: Natcher Building, NIH, Conf. Rm.

4AS–10.

Contact Person: Dr. H. George Hausch,

Chief, Review Section, 4500 Center Drive,

Natcher Building, Room 4AN–38J, Bethesda,

MD 20892, (301) 594–2372.

Purpose/Agenda: To evaluate and review

grant applications and/or contract proposals.

The meetings will be closed in accordance

with the provision set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to the meetings due to the

urgent need to meet timing limitations

imposed by the grant review cycle.

(Catalog of Federal Domestic Assistance

Program No. 93.121, Oral Diseases and

Disorders Research)

Dated: March 13, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6567 Filed 3–16–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Meeting of the Board of Scientific

Counselors

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the Board

of Scientific Counselors, National

Institute of Diabetes and Digestive and

Kidney Diseases (NIDDK), April 26–28,

1995, National Institutes of Health,

Building 5, Room 127, Bethesda,

Maryland 20892.

The meeting will be open to the

public on April 26 from 7 p.m. to 7:30

p.m. for discussions of policies of the

NIDDK Intramural Research Program.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public on

April 26 from 7:30 p.m. to 10 p.m.;

April 27 from 8:30 a.m. to 6 p.m. and

on April 28 from 9 a.m. to adjournment

for the review, discussion and

evaluation of individual intramural

programs and projects conducted by the

NIDDK, including consideration of

personnel qualifications and

performance, the competence of

individual investigations, and similar

items, disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

A summary of the meeting and roster

of members will be provided, upon

request, by the Committee Management

Office, National Institute of Diabetes

and Digestive and Kidney Diseases,

Building 31, Room 9A07, Bethesda,

Maryland 20892.

For any further information, and for

individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, please

contact Dr. Allen Spiegel, Scientific

Review Administrator, Board of

Scientific Counselors, National

Institutes of Health, Building 10, Room

9N–222, Bethesda, Maryland 20892,

(301) 496–4128, prior to the meeting.

(Catalog of Federal Domestic Assistance

Program No 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health.)

Dated: March 13, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6565 Filed 3–16–95; 8:45 am]

BILLING CODE 4140–01–M

National Library of Medicine; Notice of

Meeting of the Board of Scientific

Counselors, National Center for

Biotechnology Information, National

Library of Medicine

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the Board

of Scientific Counselors, National

Center for Biotechnology Information,

National Library of Medicine, on April

20–21, 1995.

The meeting of April 21 will be open

to the public from 9 a.m. to 3 p.m. in

the Board Room of the Library, 8600

Rockville Pike, Bethesda, Maryland, for

the review of research and development

programs and preparation of reports of

the National Center for Biotechnology

Information. Attendance by the public

will be limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. David Lipman at 301–496–

2475.

In accordance with provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.,

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public on

April 20 from 7 p.m. to approximately

10 p.m., at the Bethesda Hyatt Hotel,

and on April 21, from 3 p.m. to

approximately 5 p.m., in the Board

Room of the National Library of

Medicine, for the consideration of

personnel qualifications and

performance of individual investigators

and similar items, the disclosure of

which would constitute an unwarranted

invasion of personal privacy.

The Executive Secretary, Dr. David J.

Lipman, Director, National Center for

Biotechnology Information, National

Library of Medicine, 8600 Rockville

Pike, Bethesda, Maryland 20894,

telephone (301) 496–2475, will furnish

summaries of the meeting, rosters of

committee members, and substantive

program information.

Dated: March 13, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6568 Filed 3–16–95; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/agenda: To review individual

grant applications.

Name of SEP: Clinical Sciences.

Date: April 3, 1995.

Time: 8:30 a.m.

Place: Hyatt Regency, Bethesda, MD.

Contact person: Dr. Scott Osborne,

Scientific Review Administrator, 5333

Westbard Ave., Room 203C, Bethesda, MD

20892 (301) 594–7060.

Name of SEP: Clinical Sciences.

Date: April 3, 1995.

Time: 1:00 p.m.

Place: NIH, Westwood Building, Room

203C, Telephone Conference.

Contact person: Dr. Scott Osborne,

Scientific Review Administrator, 5333

Westbard Ave., Room 203C, Bethesda, MD

20892 (301) 594–7060.

Name of SEP: Clinical Sciences.

Date: April 3, 1995.

Time: 3 p.m.

Place: NIH, Westwood Building, Room

203C, Telephone Conference.

Contact person: Dr. Scott Osborne,

Scientific Review Administrator, 5333

Westbard Ave., Room 203C, Bethesda, MD

20892 (301) 594–7060.